Mucopolysaccharidosis Type I in Mexico: Case-Based Review.
Consuelo Cantú-ReynaDiana Laura Vazquez-CantuHéctor Cruz-CaminoYuriria Arlette Narváez-DíazÓscar Flores-CalocaÓscar González-LlanoCarolina Araiza-LozanoRené Gómez-GutiérrezPublished in: Children (Basel, Switzerland) (2023)
Despite the challenges of managing this rare disease in Mexico, our patient benefited from the combined therapy. The discrete clinical manifestations and prompt evaluation by a geneticist were crucial in establishing a diagnosis, enabling an early intervention by a multidisciplinary team. The combination of ERT before and after HSCT provided health benefits to our patient.